Covington & Burling LLP and Gibson Dunn & Crutcher LLP have advised Merck & Co., Inc. Freshfields has advised Terns Pharmaceuticals, Inc. Merck & Co., Inc.,...
Merck to Acquire Terns Pharmaceuticals for $6.7 Billion
Terns Pharmaceuticals Completes $747.5 Million Public Offering of Common Stock
Wilmer Cutler Pickering Hale and Dorr has advised Terns Pharmaceuticals. Davis Polk has advised the representative of the underwriters. Terns Pharmaceuticals, Inc., a clinical-stage oncology company...
Terns Pharmaceuticals’ $172.7 Million IPO
Wilmer Cutler Pickering Hale and Dorr and Cooley advised on Terns Pharmaceuticals, Inc. on the offering, and Davis Polk & Wardwell advised the underwriters. Terns Pharmaceuticals,...
Terns Pharmaceuticals’ $86 Million Common Stock Offering
Latham & Watkins LLP represented Terns Pharmaceuticals in the offering and Davis Polk advised the underwriters involved. Terns Pharmaceuticals, Inc. (Nasdaq: TERN), a clinical-stage biopharmaceutical company...
Terns Pharmaceuticals’ $65 Million Common Stock Offering
Latham & Watkins represented Terns Pharmaceuticals in the offering, while Davis Polk & Wardwell represented the underwriters. Terns Pharmaceuticals, Inc. (Nasdaq: TERN) has agreed to sell, by...